In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target ...
Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. The second wave of the medtech industry’s latest earnings season arrives this week, with Boston ...
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...
Canaccord Genuity analyst William Plovanic maintained a Buy rating on Boston Scientific (BSX – Research Report) on October 18 and set a ...
Boston Scientific received FDA approval for its navigation-enabled Farawave Nav ablation catheter and clearance for new ...
Boston Scientific has launched a docuseries campaign to remove the stigma of male incontinence. Across the videos, the campaign tells the stories of how incontinence upended the lives of three men ...
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns ...
The latest trading session saw Boston Scientific (BSX) ending at $84, denoting a +0.1% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily gain of 0.28%.
Boston Scientific Corporation BSX is gaining traction in the international regions. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...